Press release
Next Generation Immunotherapies Market Forecast 2025-2034: Analysing Major Trends, Opportunities, and Growth Drivers
Next Generation Immunotherapies
The increasing prevalence of cancer is expected to drive the growth of the next-generation immunotherapies market. Cancer's rising prevalence is attributed to factors such as aging, environmental exposures, lifestyle changes, and better detection methods. Next-generation immunotherapies, which boost the body's immune response against cancer, offer more targeted, durable, and personalized treatments. For instance, in May 2024, the National Cancer Institute projected that the global number of new cancer cases will reach 29.9 million by 2040, up from 20 million in 2022. This surge in cancer cases is expected to accelerate the demand for next-generation immunotherapies, driving the growth of this market.
Get Your Next Generation Immunotherapies Market Report Here:
https://www.thebusinessresearchcompany.com/report/next-generation-immunotherapies-global-market-report
What is the future CAGR of the next generation immunotherapies market, and how will it impact industry expansion?
The next-generation immunotherapies market has grown rapidly, increasing from $133.81 billion in 2024 to $150.54 billion in 2025 at a CAGR of 12.5%. Growth has been fueled by the increasing prevalence of cancer, rising R&D investments, government initiatives, higher healthcare spending, and the expansion of treatment indications.
The next-generation immunotherapies market is set for rapid expansion, reaching $238.04 billion by 2029, with a CAGR of 12.1%. This growth will be fueled by the increasing prevalence of cancer, rising healthcare expenditures, higher adoption of chimeric antigen receptor (CAR) T-cell therapy, a growing burden of chronic diseases, and significant research in next-generation drug development. Notable trends include a shift towards combination therapies, breakthroughs in therapeutic technologies, advancements in personalized medicine, and improvements in regulatory frameworks.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21231&type=smp
What are the most significant trends transforming the next generation immunotherapies market today?
In the next-generation immunotherapies market, companies are focusing on developing innovative therapies such as CAR T-cell therapy to treat cancers, autoimmune diseases, and infectious diseases. For instance, in January 2025, Immuneel Therapeutics Private Limited, an India-based cell and gene therapy startup, launched Qartemi, India's first CAR T-cell therapy for B-cell non-Hodgkin lymphoma. This therapy involves genetically modifying a patient's immune cells to target and destroy cancer cells, providing a highly personalized treatment approach. It offers a promising and more affordable alternative compared to global CAR T-cell therapies, giving hope to patients for whom conventional treatments have failed.
Which key market segments comprise the next generation immunotherapies market and drive its revenue growth?
The next generation immunotherapies market covered in this report is segmented -
1) By Drug Class: Monoclonal Antibodies, Antibody-Drug Conjugates - ADC's, Angiotensin-Converting Enzyme (ACE) Inhibitors, Immune Checkpoint Inhibitors
2) By Route Of Administration: Intravenous, Parenteral, Intratumoral, Subcutaneous, Oral
3) By Distribution Channel: Hospital Pharmacies, Clinical Pharmacies, Other Distribution channels
Subsegments:
1) By Monoclonal Antibodies: Anti-PD-1 Antibodies, Anti-PD-L1 Antibodies, Anti-CTLA-4 Antibodies, Anti-CD20 Antibodies, Other Monoclonal Antibodies
2) By Antibody-Drug Conjugates (ADC's): HER2-targeted ADCs, CD30-targeted ADCs, CD19-targeted ADCs, Other ADCs
3) By Angiotensin-Converting Enzyme (ACE) Inhibitors: ACE Inhibitors For Cancer Therapy, ACE Inhibitors For Other Indications
4) By Immune Checkpoint Inhibitors: PD-1 Or PD-L1 Inhibitors, CTLA-4 Inhibitors, Other Immune Checkpoint Inhibitors
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21231
What regions are at the forefront of next generation immunotherapies market expansion?
North America was the largest region in the next-generation immunotherapies market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the next generation immunotherapies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Who are the leading players fueling growth in the next generation immunotherapies market?
Major companies operating in the next generation immunotherapies market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca PLC, Novartis AG, GlaxoSmithKline plc (GSK), Eli Lilly and Company, Gilead Sciences Inc., Amgen Inc., Boehringer Ingelheim International GmbH, Regeneron Pharmaceuticals Inc., Incyte Corporation, BioNTech SE, Xencor Inc., Fate Therapeutics Inc., Immatics N.V., Atara Biotherapeutics Inc., Menarini Group, Alpine Immune Sciences Inc., Mereo Biopharma Group plc, Immunomic Therapeutics Inc., Indaptus Therapeutics Inc.
Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=21231&type=smp
What Is Covered In The Next Generation Immunotherapies Global Market Report?
•Market Size Forecast: Examine the next generation immunotherapies market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the next generation immunotherapies market for a structured understanding.
•Key Players Overview: Analyze major players in the next generation immunotherapies market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the next generation immunotherapies market.
•Segment Contributions: Evaluate how different segments drive overall growth in the next generation immunotherapies market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the next generation immunotherapies market.
•Industry Challenges: Identify potential risks and obstacles affecting the next generation immunotherapies market.
•Competitive Landscape: Review strategic developments in the next generation immunotherapies market, including expansions, agreements, and new product launches.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Next Generation Immunotherapies Market Forecast 2025-2034: Analysing Major Trends, Opportunities, and Growth Drivers here
News-ID: 3934536 • Views: …
More Releases from The Business Research Company
Increasing Prevalence Of Nasal Disorders Driving Growth Of The Market: Strategic …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Rhinoscope Devices Market Size By 2025?
In recent times, the rhinoscope devices market has seen significant growth. The market, which was worth $4.74 billion in 2024, is expected to expand to $5.05 billion in 2025, marking a compound annual growth rate (CAGR) of 6.5%. The…
Future of the Antimicrobial Resistance Surveillance Market: Trends, Innovations, …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Antimicrobial Resistance Surveillance Market Size Growth Forecast: What to Expect by 2025?
The market size for antimicrobial resistance surveillance has experienced robust growth lately. The market, which was valued at $6.77 billion in 2024, is predicted to expand to $7.3 billion in 2025, demonstrating a compound annual growth rate…
Thoracic Drainage Devices Market Insights 2025-2034: Growth Forecast and Strateg …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Thoracic Drainage Devices Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market size for thoracic drainage devices has seen considerable growth in the past few years. The market is projected to expand from a value of $0.89 billion in 2024 to an estimated $0.96…
Comprehensive 2025 Percutaneous Mechanical Circulatory Support Devices Market Ov …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Percutaneous Mechanical Circulatory Support Devices Market Through 2025?
In recent times, there has been significant growth in the market size of percutaneous mechanical circulatory support devices. The industry, which is currently valued at $2.26 billion in 2024, is projected to increase to…
More Releases for Inhibitors
Thymidine Phosphorylase Inhibitors Market - Breaking the Cycle: Angiogenesis Inh …
Newark, New Castle, USA: The "Thymidine Phosphorylase Inhibitors Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Thymidine Phosphorylase Inhibitors Market: https://www.growthplusreports.com/report/thymidine-phosphorylase-inhibitors-market/8826
This latest report researches the industry structure,…
CGRP Inhibitors Market - Break Free from Migraine: CGRP Inhibitors Redefining Re …
Newark, New Castle, USA - The latest report from Growth Plus Reports analyzes the production, potential applications, demand, major manufacturers, and SWOT analysis of the global CGRP Inhibitors Market.
CGRP Inhibitors Market: https://www.growthplusreports.com/report/cgrp-inhibitors-market/9155
The CGRP Inhibitors Market Report assists in determining the optimum distribution methods for certain products as well as possible markets for future product launches. The report also analyses the purchase and supply trends that influence the market's production strategy.…
Immune Checkpoint Inhibitors Market: Current Evidence And Future Perspectives Of …
Stratagem Market Insights delivers key insights for the Immune Checkpoint Inhibitors market in its published report, which include global industry analysis, Size, Growth, Opportunities, Emerging Trends, Challenges, and Geographic Regions over the forecast period (2021-2028). In terms of revenue, the global Immune Checkpoint Inhibitors market is projected to grow at a CAGR of XX% during the forecast period, owing to several factors about which SMI offers detailed insights and forecasts…
Crude Oil Flow Improvers Market by Type (Paraffin Inhibitors, Asphaltene Inhibit …
Global Crude Oil Flow Improvers Market was valued at $1,282 million in 2016, and is anticipated to reach $1,920 million, growing at a CAGR of 5.7% from 2017 to 2023. Crude oil is one of the most actively traded commodities with a stable growth rate globally. It is extracted from remote locations and needs to be transported through pipelines. Transportation of crude oil via pipeline is relatively difficult, owing to…
Immune Check Point Inhibitors Market Immune Check Point Inhibitors Clinical Pipe …
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
Immune Checkpoint Inhibitors- Introduction to Next Generation Cancer Immunotherapy
1.1 Overview
1.2 History- From Tragedy to Breakthrough
Major Immune Checkpoints Proteins
2.1 Role of Cytotoxic T lymphocyte Antigen-4 (CTLA-4) in Cancer Development
2.2 Role of Programed Cell Death Protein 1 (PD1) in Cancer Development
Mechanism of Action of Immune Checkpoint Inhibitors
3.1 Cytotoxic T lymphocyte Antigen-4…
Global Immune Check Point Inhibitors Market & Immune Check Point Inhibitors Clin …
Immunotherapy represents a paradigm shift in oncology therapy along the multiple fronts. Although, targeted therapy upgrades the underlying signaling defect which results in oncogenesis within the tumor. The immune checkpoint blockade is fundamentally a therapy which directed at the patient's native immune system to tilt the immune homeostasis away from self-tolerance towards cytotoxicity, with the goal of inducing antitumor immunity.
The immune checkpoint inhibitors such as ipilimumab, nivolumab and pembrolizumab…
